A clinical available decision support scheme for optimizing prostate biopsy based on mpMRI.
Ying HouKe-Wen JiangJing ZhangMei-Ling BaoHai-Bin ShiJin-Rong QuGong ChengYu-Dong ZhangPublished in: Prostate cancer and prostatic diseases (2022)
The benefit of SBx added to TBx was largely restricted to smaller PI-RADS score 3-4 lesions. Using our personalized strategy of solo TBx for PI-RADS 5 and larger (≥1 cm) PI-RADS score 3-4 lesions would avoid excess SBx in 44.5% (102/229) of all biopsy-naïve patients without compromising detection rate.